You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

GI neuroendocrine NET

Showing 1 - 25 of 3,032
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neuroendocrine Tumors, Neuroendocrine Tumor of the Lung, Neuroendocrine Tumor of Pancreas Trial in Iowa City, Rochester

Not yet recruiting
  • Neuroendocrine Tumors
  • +8 more
  • Iowa City, Iowa
  • +1 more
Nov 23, 2022

Neuroendocrine Tumors, Carcinoid Tumor of GI System, Diarrhea Trial in Lexington (Amino Acid Based Medical Food/Drink)

Completed
  • Neuroendocrine Tumors
  • +3 more
  • Amino Acid Based Medical Food/Drink
  • Lexington, Kentucky
    University of Kentucky Markey Cancer Center
Nov 2, 2022

Quality of Life Trial in Belgium (EORTC QLQ-C30, EORTC QLQ-GI.NET21, Satisfaction survey)

Recruiting
  • Quality of Life
  • EORTC QLQ-C30
  • +2 more
  • Brasschaat, Antwerp, Belgium
  • +6 more
Mar 8, 2022

Neuroendocrine Tumors, Carcinoid Syndrome, Diarrhea Trial in Iowa City (Telotristat ethyl, Peptide Receptor Radionuclide

Withdrawn
  • Neuroendocrine Tumors
  • +2 more
  • Telotristat ethyl
  • +2 more
  • Iowa City, Iowa
    University of Iowa Hospital and Clinics
Feb 9, 2022

Neuroendocrine Tumors, Neuroendocrine Tumor of the Lung, Neuroendocrine Tumor Grade 1 Trial in Iowa City ([212Pb] VMT-a-NET,

Recruiting
  • Neuroendocrine Tumors
  • +4 more
  • [212Pb] VMT-α-NET
  • [203Pb] VMT-α-NET SPECT/CT
  • Iowa City, Iowa
    Holden Comprehensive Cancer Center at the University of Iowa
Nov 30, 2023

Collect Somatuline® Injector Device Preferences of Patients

Not yet recruiting
  • Neuroendocrine Tumors
    • (no location specified)
    Jun 19, 2023

    Neuroendocrine Tumor Grade 2, Neuroendocrine Tumor Grade 1 Trial ([203Pb]VMT-a-NET, SPECT/CT)

    Enrolling by invitation
    • Neuroendocrine Tumor Grade 2
    • Neuroendocrine Tumor Grade 1
    • Iowa City, Iowa
      The University of Iowa
    Dec 9, 2022

    Neuroendocrine Tumors, NET, Pancreatic Neuroendocrine Tumor Trial in Newport Beach, Denver, Dallas (nab-sirolimus)

    Not yet recruiting
    • Neuroendocrine Tumors
    • +4 more
    • Newport Beach, California
    • +2 more
    Aug 16, 2023

    Quality of Life and Tolerance of Patients Treated With

    Not yet recruiting
    • Metastatic Neuroendocrine Tumour
      • Lyon, France
        Hospices Civils de Lyon, Hopital Lyon Sud
      Sep 12, 2023

      Gastroenteropancreatico Tumors, Neuroendocrine Tumors, Neuroendocrine Tumors Trial run by the National Cancer Institute (NCI)

      Recruiting
      • Gastroenteropancreatico Tumors
      • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 19, 2023

      Well-differentiated Non-functional NET of Thoracic Origin, Well-differentiated Non-functional NET of Gastrointestinal Origin,

      Completed
      Has Results
      • Well-differentiated Non-functional NET of Thoracic Origin
      • +3 more
      • Duarte, California
      • +34 more
      Mar 16, 2021

      GEP-NET, Gastroenteropancreatic Neuroendocrine Tumor, Gastroenteropancreatic Neuroendocrine Tumor Disease Trial in United States

      Recruiting
      • GEP-NET
      • +6 more
      • Duarte, California
      • +3 more
      Jul 28, 2022

      Neuroendocrine Tumours (NET), Neuroendocrine Carcinomas (NEC) Trial in Spain (177Lu-Dotatate, Nivolumab)

      Recruiting
      • Neuroendocrine Tumours (NET)
      • Neuroendocrine Carcinomas (NEC)
      • Santiago De Compostela, Galicia, Spain
      • +4 more
      Aug 1, 2022

      Metastatic Midgut Neuroendocrine Tumor, Unresectable Midgut Neuroendocrine Tumor Trial (procedure, drug, other)

      Not yet recruiting
      • Metastatic Midgut Neuroendocrine Tumor
      • Unresectable Midgut Neuroendocrine Tumor
      • Biospecimen Collection
      • +5 more
      • (no location specified)
      Mar 16, 2023

      Small-cell Lung Cancer, Neuroendocrine Carcinoma Trial (Iadademstat, Paclitaxel)

      Not yet recruiting
      • Small-cell Lung Cancer
      • Neuroendocrine Carcinoma
      • (no location specified)
      Jun 13, 2022

      Neuroendocrine Tumor (NET), Colorectal Cancer (CRC) Trial (CHM-2101 CAR-T cells)

      Not yet recruiting
      • Neuroendocrine Tumor (NET)
      • Colorectal Cancer (CRC)
      • CHM-2101 CAR-T cells
      • (no location specified)
      Sep 20, 2023

      68Ga-DOTATOC Radio-Guided Surgery With ß-Probe in GEP-NET

      Recruiting
      • Neuroendocrine Tumor Carcinoid
      • +2 more
        • Milan, Italy
          IRCCS Istituto Europeo di Oncologia S.r.l.
        Jul 8, 2022

        Small Cell Lung Cancer (SCLC), Large Cell Neuroendocrine Cancer (LCNEC), Neuroendocrine Prostate Cancer (NEPC) Trial (PT217)

        Not yet recruiting
        • Small Cell Lung Cancer (SCLC)
        • +3 more
        • (no location specified)
        Dec 7, 2022

        Neuroendocrine Tumors - Patient Reported Outcomes

        Enrolling by invitation
        • Neuroendocrine Tumors
        • +3 more
          • Gainesville, Florida
          • +13 more
          Jul 7, 2022

          GEP-NET, Neuroendocrine Tumors, Neuroendocrine Carcinoma Trial in Copenhagen (18F-FDG, 64Cu-Dotatate)

          Enrolling by invitation
          • GEP-NET
          • +3 more
          • Copenhagen, Denmark
            Rigshospitalet
          Jan 24, 2023

          DOTATOC PET/CT for Imaging NET Patients

          Recruiting
          • Neuroendocrine Tumors
          • +15 more
          • 68Ga-DOTATOC PET/CT
          • 18F-FDG PET/CT
          • Vancouver, British Columbia, Canada
            BC Cancer
          Nov 2, 2022

          68Ga-HA-DOTATATE PET/CT in Adults With Neuroendocrine Tumors

          Recruiting
          • Neuroendocrine Tumors (NET)
          • 68Ga-HA-DOTATATE PET/CT imaging
          • Calgary, Alberta, Canada
            Foothills Medical Center 1403 29 St NW
          Jan 4, 2023

          Lutathera® in Somatostatin Receptor Positive

          Recruiting
          • Somatostatin Receptor-positive GEP-NET
          • Lutathera
          • Seongnam Si, Gyeonggi Do, Korea, Republic of
          • +4 more
          Jun 29, 2022

          Advanced NET of GI Origin, Advanced NET of Lung Origin, Neuroendocrine Tumors Trial in Worldwide (Everolimus, Placebo, Best

          Completed
          Has Results
          • Advanced NET of GI Origin
          • +2 more
          • La Jolla, California
          • +96 more
          Jul 13, 2021

          Neuroendocrine Tumor Grade 2, Neuroendocrine Tumors Trial in Little Rock, Buffalo, Philadelphia (Capecitabine Oral Product,

          Recruiting
          • Neuroendocrine Tumor Grade 2
          • Liver Metastases
          • Capecitabine tablets + temozolomide tablets + SIR-Spheres
          • Philadelphia, Pennsylvania
            Abramson Cancer Center
          Oct 1, 2021